Landmark EchoCRT Trial enrolls first European patients


The EchoCRT trial is designed to demonstrate that optimal medical therapy plus CRT reduces all-cause mortality or first hospitalisation for worsening heart failure in the study population compared to optimal medical therapy alone. Eligible patients must have echocardiographic evidence of left ventricular dyssynchrony (discoordinated pumping action of the heart) with a

Published on : Tue, 9 Dec 2008


Print as PDF
The EchoCRT trial is designed to demonstrate that optimal medical therapy plus CRT reduces all-cause mortality or first hospitalisation for worsening heart

No comment


Please login to leave a comment...